EcoDrugPlus

Ensembl ID : ENSMAUG00000015485
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSMAUG00000014224
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Ensembl ID : ENSMAUG00000001305
Gene Symbol: -
Cross references: -
86 Possible Orthologues:

Ensembl ID : ENSMAUG00000009392
Gene Symbol: -
Cross references: -
241 Possible Orthologues:

Ensembl ID : ENSMAUG00000008307
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSMAUG00000018984
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSMAUG00000015428
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSMAUG00000004168
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSMAUG00000004738
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSMAUG00000013985
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSMAUG00000008504
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSMAUG00000014910
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).